AFYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Afya Ltd is not a strong buy at this time for a beginner investor with a long-term strategy. Despite positive financial growth in the latest quarter, the stock faces significant headwinds, including insider selling, analyst downgrades, and a lack of positive trading signals. The technical indicators show some bullish momentum, but the absence of strong catalysts and the negative sentiment from analysts and insiders suggest holding off on investing in this stock for now.
The stock shows bullish momentum with MACD positively expanding and bullish moving averages (SMA_5 > SMA_20 > SMA_200). RSI is neutral at 73.133, and the stock is trading near its resistance level of 15.681. However, the stock's trend analysis indicates a 60% chance of a decline in the next day (-0.58%), week (-2.83%), and month (-6.7%).
The company's financial performance in Q4 2025 showed revenue growth of 7.54% YoY, net income growth of 15.36% YoY, and EPS growth of 15.15% YoY.
Insider selling has increased by 1175.28% over the last month.
Analysts have downgraded the stock multiple times recently, citing concerns over margin pressure, slower volume growth, and increased investments in non-core businesses.
No recent news or event-driven catalysts to support positive sentiment.
Options data indicates bearish sentiment with a high Open Interest Put-Call Ratio of 2.07.
In Q4 2025, Afya Ltd reported revenue of 912,990,000, up 7.54% YoY. Net income increased to 172,962,000, up 15.36% YoY. EPS rose to 1.9, up 15.15% YoY. However, gross margin dropped to 61.81, down -3.15% YoY, indicating potential pressure on profitability.
Recent analyst actions have been negative. BofA, Morgan Stanley, BTG Pactual, and UBS all downgraded the stock, with price targets reduced to $16-$17. Analysts cite concerns over margin pressure, slower growth, and increased investments in non-core businesses.
